Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a Parkinson's drug help treat anhedonic depression long-term?

NCT ID NCT05825235

First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study looked at whether adding pramipexole to usual treatment can help people with anhedonic depression (depression with a loss of interest or pleasure) over six months. 55 adults who had already been in a shorter trial took pramipexole as an add-on. Researchers measured changes in anhedonia and other depression symptoms, as well as side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Region Skåne

    Lund, Skåne County, 221 85, Sweden

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pramipexole (a drug used for Parkinson's and restless legs, tested here for depression with loss of interest)

What this could lead to

If it works, this could offer a new long-term treatment option for people with depression who struggle with loss of interest or pleasure.

What could go wrong

This is a small, open-label follow-up study with no placebo group, so results may be less reliable. Side effects of pramipexole can include nausea, dizziness, and impulse control issues.

Conditions

The condition(s) this trial relates to.

Anhedonia Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.